Brief: Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing
05/06/2026 12:18
BRIEF-Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing June 5 (Reuters) - Climb Bio Inc CLYM.O:
CLIMB BIO - ANNOUNCES INITIAL PHASE 1 SAFETY DATA FOR CLYM116 - SEC FILING
CLIMB BIO - NO SERIOUS ADVERSE EVENTS OR DOSE LIMITING TOXICITIES OBSERVED FOR CLYM116 IN PHASE 1 - SEC FILING
Further company coverage: CLYM.O
((Reuters.Briefs@thomsonreuters.com;))